CoChat

Multitargeted Nanoparticles Deliver Synergistic Drugs across the Blood–Brain Barrier to Brain Metastases of Triple Negative Breast Cancer Cells and Tumor‐Associated Macrophages

Zhang, Tian, Lip, Hoyin, He, Chunsheng, Cai, Ping, Wang, Zhigao, Henderson, Jeffrey T., Rauth, Andrew M., Wu, Xiao Yu · 2019 · Advanced Healthcare Materials
Cited by 81

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Patients with brain metastases of triple negative breast cancer (TNBC) have a poor prognosis owing to the lack of targeted therapies, the aggressive nature of TNBC, and the presence of the blood–brain barrier (BBB) that blocks penetration of most drugs. Additionally, infiltration of tumor‐associated macrophages (TAMs) promotes tumor progression. Here, a terpolymer‐lipid hybrid nanoparticle (TPLN) system is designed with multiple targeting moieties to first undergo synchronized BBB crossing and then actively target TNBC cells and TAMs in microlesions of brain metastases. In vitro and in vivo studies demonstrate that covalently bound polysorbate 80 in the terpolymer enables the low‐density lipoprotein receptor‐mediated BBB crossing and TAM‐targetability of the TPLN. Conjugation of cyclic internalizing peptide (iRGD) enhances cellular uptake, cytotoxicity, and drug delivery to brain metastases of integrin‐overexpressing TNBC cells. iRGD‐TPLN with coloaded doxorubicin (DOX) and mitomycin C (MMC) (iRGD‐DMTPLN) exhibits higher efficacy in reducing metastatic burden and TAMs than nontargeted DMTPLN or a free DOX/MMC combination. iRGD‐DMTPLN treatment reduces metastatic burden by 6‐fold and 19‐fold and increases host median survival by 1.3‐fold and 1.6‐fold compared to DMTPLN or free DOX/MMC treatments, respectively. These findings suggest that iRGD‐DMTPLN is a promising multitargeted drug delivery system for the treatment of integrin‐overexpressing brain metastases of TNBC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/adhm.201900543

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 81

Metadata

Authors
Zhang, T., Lip, H., He, C., Cai, P., Wang, Z., Henderson, J. T., Rauth, A. M., & Wu, X. Y.
Venue
Advanced Healthcare Materials
Publisher
Wiley
Published
2019-07-26
Volume
8
Issue
18
Pages
e1900543-e1900543
ISSN
  • 2192-2640 (ISSN-L)
  • 2192-2659
OpenAlex
W2964883171
Cited by
81
References
11
FWCI
2.72
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.